Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562316816> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2562316816 abstract "In drug development, animal toxicology data are very important for the evaluation of clinical safety. We quantitatively assessed the safety profiles of blood cancer drugs approved in Japan from category I (high) to V (low). We examined the ratios of drug exposure in animals at the no observed adverse effect level to those in humans at the expected therapeutic dose. In addition, qualitative analysis of the relationship between toxicological findings and adverse drug reactions (ADRs) is one of the primary approaches for determining the risk-benefit profile of a pharmaceutical. This study thus aimed to evaluate the potential of nonclinical safety assessments for predicting ADRs in humans.We examined toxicological findings at the lowest observed adverse effect level and ADRs in pivotal clinical studies. We calculated concordance rates as the ratio of the number of concordant ADRs to all ADRs.Twenty-seven drugs were eligible for analysis. Concordance rates ranged from 0 to 84.8%. No significant differences were observed in concordance rates between antibodies (median 14.3%) and small molecules (median 18.5%). There was a significant correlation between concordance rates and quantitative safety profiles (p = 0.047), suggesting that some drugs with low safety profiles (categories III, IV, or V) have high concordance rates.The results suggested that ADRs in clinical trials could be predicted based on toxicity data obtained in animal tests, especially for some drugs with a low quantitative safety profile." @default.
- W2562316816 created "2017-01-06" @default.
- W2562316816 creator A5012257010 @default.
- W2562316816 creator A5052697086 @default.
- W2562316816 creator A5064565934 @default.
- W2562316816 creator A5091099191 @default.
- W2562316816 date "2016-12-19" @default.
- W2562316816 modified "2023-10-08" @default.
- W2562316816 title "Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan" @default.
- W2562316816 cites W1858470303 @default.
- W2562316816 cites W1972648266 @default.
- W2562316816 cites W1979079966 @default.
- W2562316816 cites W2064876070 @default.
- W2562316816 cites W2081668170 @default.
- W2562316816 cites W2104209550 @default.
- W2562316816 cites W2156801000 @default.
- W2562316816 cites W2185365308 @default.
- W2562316816 cites W2187141863 @default.
- W2562316816 cites W2275687210 @default.
- W2562316816 cites W2413406085 @default.
- W2562316816 doi "https://doi.org/10.1007/s40268-016-0160-x" @default.
- W2562316816 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5318328" @default.
- W2562316816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27995532" @default.
- W2562316816 hasPublicationYear "2016" @default.
- W2562316816 type Work @default.
- W2562316816 sameAs 2562316816 @default.
- W2562316816 citedByCount "0" @default.
- W2562316816 crossrefType "journal-article" @default.
- W2562316816 hasAuthorship W2562316816A5012257010 @default.
- W2562316816 hasAuthorship W2562316816A5052697086 @default.
- W2562316816 hasAuthorship W2562316816A5064565934 @default.
- W2562316816 hasAuthorship W2562316816A5091099191 @default.
- W2562316816 hasBestOaLocation W25623168161 @default.
- W2562316816 hasConcept C126322002 @default.
- W2562316816 hasConcept C160798450 @default.
- W2562316816 hasConcept C197934379 @default.
- W2562316816 hasConcept C2780035454 @default.
- W2562316816 hasConcept C29730261 @default.
- W2562316816 hasConcept C2993432071 @default.
- W2562316816 hasConcept C535046627 @default.
- W2562316816 hasConcept C71924100 @default.
- W2562316816 hasConcept C98274493 @default.
- W2562316816 hasConceptScore W2562316816C126322002 @default.
- W2562316816 hasConceptScore W2562316816C160798450 @default.
- W2562316816 hasConceptScore W2562316816C197934379 @default.
- W2562316816 hasConceptScore W2562316816C2780035454 @default.
- W2562316816 hasConceptScore W2562316816C29730261 @default.
- W2562316816 hasConceptScore W2562316816C2993432071 @default.
- W2562316816 hasConceptScore W2562316816C535046627 @default.
- W2562316816 hasConceptScore W2562316816C71924100 @default.
- W2562316816 hasConceptScore W2562316816C98274493 @default.
- W2562316816 hasLocation W25623168161 @default.
- W2562316816 hasLocation W25623168162 @default.
- W2562316816 hasLocation W25623168163 @default.
- W2562316816 hasLocation W25623168164 @default.
- W2562316816 hasOpenAccess W2562316816 @default.
- W2562316816 hasPrimaryLocation W25623168161 @default.
- W2562316816 hasRelatedWork W1987189695 @default.
- W2562316816 hasRelatedWork W2018736125 @default.
- W2562316816 hasRelatedWork W2023487034 @default.
- W2562316816 hasRelatedWork W2049177675 @default.
- W2562316816 hasRelatedWork W2074943124 @default.
- W2562316816 hasRelatedWork W2136904701 @default.
- W2562316816 hasRelatedWork W2142225926 @default.
- W2562316816 hasRelatedWork W2376738370 @default.
- W2562316816 hasRelatedWork W2397868246 @default.
- W2562316816 hasRelatedWork W2402651161 @default.
- W2562316816 isParatext "false" @default.
- W2562316816 isRetracted "false" @default.
- W2562316816 magId "2562316816" @default.
- W2562316816 workType "article" @default.